U.S. market Closed. Opens in 2 days 1 hour 30 minutes

ICPT | Intercept Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Revenue285.71M363.47M312.69M252.00M179.80M130.96M24.95M2.78M1.74M1.62M2.45M1.81MN/A
Cost of Revenue984.00K3.10M5.32M4.21M2.52M1.37MN/AN/AN/AN/AN/AN/AN/A
Gross Profit284.73M360.37M307.37M247.79M177.28M129.59M24.95M2.78MN/AN/AN/A1.81MN/A
Operating Expenses352.94M416.13M523.98M560.22M462.77M465.20M427.49M231.94M114.91M41.07M21.36M15.64MN/A
Selling, General & Admin176.30M230.85M332.49M317.42M255.47M273.70M273.60M103.75M34.60M13.13M5.18MN/AN/A
Research & Development176.64M185.27M191.49M242.80M207.30M191.50M153.89M128.19M80.31M27.94M16.18M11.43M12.71M
Other Operating Expenses6.52M2.15M4.41M8.89M6.77MN/AN/AN/AN/AN/AN/A4.21MN/A
Operating Income-68.22M-55.76M-216.61M-312.43M-285.49M-335.61M-402.54M-229.16M-113.17M-39.45M-18.91M-13.83M-15.86M
Other Expenses / Income-106.64M-35.67M-58.27M-32.25M6.77M-24.75M-10.29M2.73M-170.06M-28.34M-24.73M1.04M777.03K
Before Tax Income-174.86M-91.43M-274.88M-344.68M-309.24M-360.37M-412.83M-226.43M-283.23M-67.79M-43.64MN/A-15.09M
Income Tax Expenses-290.03M53.60M49.35M46.37M6.77MN/AN/AN/AN/AN/AN/AN/AN/A
Net Income115.17M-145.02M-324.23M-391.05M-309.24M-360.37M-412.83M-226.43M-283.23M-67.79M-43.64M-12.74M-15.09M
Interest Expenses21.39M54.42M48.05M41.14M30.52M29.27M14.20MN/AN/AN/AN/A13.48KN/A
Basic Shares Outstanding33.82M31.86M32.97M31.65M28.46M25.05M24.66M23.69M20.78M18.03M6.28M10.73M3.33M
Diluted Shares Outstanding33.84M31.89M32.97M31.65M28.46M25.05M24.66M23.69M20.78M18.03M6.28M10.73M3.33M
EBITDA-61.70M-53.60M-212.20M-303.54M-278.72M-326.50M-394.80M-224.74M-282.78M-67.69M-43.44M-12.31M-16.06M
EBITDA Margin-21.59%-14.75%-67.86%-120.45%-155.01%-249.32%-1,582.31%-8,078.29%-16,236.81%-4,174.00%-1,775.96%-682.14%0.00%
EBIT-153.47M-37.01M-226.83M-303.54M-271.95M-331.10M-398.63M-226.43M-283.23M-67.79M-43.64M-12.72M-15.09M
EBIT Margin-53.72%-10.18%-72.54%-120.45%-151.25%-252.83%-1,597.67%-8,139.07%-16,262.23%-4,180.52%-1,784.19%-704.89%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙